Page 3 - Metastatic castration-naive and castration-sensitive prostate cancer: CUA/CUOG
P. 3
Background
• Metastatic prostate cancer remains an incurable disease
• In Canada, approximately 8% of men with prostate cancer are diagnosed
de novo with metastatic disease
• Men with de novo metastatic PC have a poor prognosis, with an estimated
median overall survival of approximately 3–4 years
• Compared to PC that develops metastases after diagnosis, de novo
metastatic PC has been shown to have a worse prognosis
PC: prostate cancer
